Australia's most trusted
source of pharma news
Saturday, 05 April 2025
Posted 4 April 2025 PM
It's been a year of belt-tightening across pharma with many companies downsizing their workforces and expenditure but for the CEOs driving those changes it's been good for the hip pocket.
Compensation paid to company leaders is going up, with most Boards awarding the pay rises as acknowledgment for the hard work required for business transformation. For some CEOs the boost to their pay packet in 2024 was substantial.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.